AI Policy
To ensure transparency and maintain high standards, we utilize AI technology in various aspects of manuscript evaluation and production. Below are the tasks where AI is employed and measures to ensure human oversight and data privacy.
I. Manuscript Verification
1. Text Consistency, Grammar, and Spelling: AI tools screen for grammatical errors, spelling mistakes, and other text deficiencies. Authors receive detailed reports highlighting deficiencies and providing clear recommendations for corrections.
2. Plagiarism Check: AI conducts plagiarism checks and generates reports for authors. In cases of minor similarities, recommendations are provided for corrections. Major instances of misconduct result in a rejection recommendation, with final decisions made by human editors.
3. Paper-Mill Flags and Risk Assessment: AI screens for indicators of paper mills and assesses risks. If red flags are detected, authors receive reports with recommendations for additional information. Experts decide on manuscript acceptance or rejection based on the AI report and author clarifications.
4. References Check: AI verifies the style, accuracy, and completeness of references and checks citations for correct numbering within the text.
5. Title Evaluation: AI evaluates titles based on the original title, abstract, and methods sections. Authors are provided with suggestions for clearer and more representative titles for approval.
II. Correspondence with Authors To promote inclusiveness, we allow authors from non-English speaking countries to write messages in their native languages. AI tools automatically translate these messages into English, facilitating more precise and accurate communication with editors. Authors can review and edit their messages before sending them to ensure accuracy.
III. Journal Page
Text-to-Audio Abstract Conversion: AI converts abstract text into audio files. Editors supervise and adjust the process to ensure accuracy and clarity.
Ethical Considerations and Human Oversight Associated with AI Implementation Into Editorial Process.
Human editors and reviewers oversee all AI-assisted processes to ensure quality and reliability. Human experts, not AI systems, make final decisions on manuscripts. We take measures to prevent AI tools from introducing bias into the evaluation process and to maintain adherence to ethical standards.
Data Privacy and Confidentiality: We maintain strict data privacy and confidentiality standards in compliance with relevant regulations. Authors' data is protected throughout the AI processing stages.
Feedback and Accountability: Authors and reviewers are encouraged to provide feedback on the AI tools used in the editorial process. The following accountability measures are in place to address any issues that may arise from AI involvement:
Human Oversight: Human editors and reviewers are involved in all stages of the manuscript evaluation process. Human experts make final decisions on manuscript acceptance, rejection, or revisions.
Feedback Channels: We provide channels for authors and reviewers to report issues or concerns regarding AI-generated outputs. A formal process is established for continuously reviewing and addressing feedback and complaints related to AI use.
Accuracy and Fairness Assessment: We regularly assess AI tools for fairness to ensure they do not disproportionately impact any group of authors.
Regular Audits and Reviews: AI tools are periodically audited to evaluate their performance and accuracy. Identified errors or biases are corrected promptly.
In Press
Original article
Post-Donation Regret and Anxiety Among Family Living Liver Donors: The Mediating Roles of Family Relationsh...Ann Transplant In Press; DOI: 10.12659/AOT.944176
Original article
Effect of the Organ Donation Quality System on Donation Activity of Warsaw HospitalsAnn Transplant In Press; DOI: 10.12659/AOT.943520
Original article
Clonal Hematopoiesis-Associated Gene Mutations Affect Acute Graft-Versus-Host Disease After Hematopoietic S...Ann Transplant In Press; DOI: 10.12659/AOT.943688
Original article
Impact of Recipient and Donor Body Mass Index on Survival Outcomes After Intestinal Transplantation: A Unit...Ann Transplant In Press; DOI: 10.12659/AOT.943994
Most Viewed Current Articles
05 Apr 2022 : Original article 12,201
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 8,720
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
12 Jan 2022 : Original article 8,640
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
15 Mar 2022 : Case report 6,496
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860